Lipocine Inc. (LPCN)
NASDAQ: LPCN · Real-Time Price · USD
4.898
+0.098 (2.04%)
At close: Dec 24, 2024, 4:00 PM
4.840
-0.058 (-1.19%)
Pre-market: Dec 26, 2024, 5:41 AM EST
Lipocine Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Lipocine stock has a target of 10, which predicts an increase of 104.16% from the current stock price of 4.90.
Analyst Consensus: Strong Buy
* Price targets were last updated on Sep 24, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for Lipocine is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Alliance Global Partners | Alliance Global Partners | Strong Buy Initiates $10 | Strong Buy | Initiates | $10 | +104.16% | Sep 24, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $33 | Buy | Reiterates | $33 | +573.73% | Jul 27, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $43 → $60 | Strong Buy | Maintains | $43 → $60 | +1,114.76% | Aug 26, 2021 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $51 | Buy | Initiates | $51 | +941.22% | Jun 24, 2021 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $51 → $43 | Strong Buy | Maintains | $51 → $43 | +767.68% | May 27, 2021 |
Financial Forecast
Revenue This Year
9.24M
from -2.85M
Revenue Next Year
3.52M
from 9.24M
Decreased by -61.96%
EPS This Year
-0.77
from -3.14
EPS Next Year
-1.24
from -0.77
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 10.8M | 5.2M | 33.1M | |||
| Avg | 9.2M | 3.5M | 17.4M | |||
| Low | 7.6M | 1.9M | 2.6M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | -43.2% | 841.3% | |||
| Avg | - | -62.0% | 395.0% | |||
| Low | - | -79.9% | -27.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.77 | -0.99 | 0.97 |
| Avg | -0.77 | -1.24 | -0.12 |
| Low | -0.76 | -1.47 | -1.13 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.